biotech
Bharat Biotech completes trials for India’s first intranasal Covid vaccine, says it’s safe, immunoge-
By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials ...
Covaxin safe, well-tolerated in 2-18 years age-group, Bharat Biotech cites Lancet study-
By Online Desk Bharat Biotech International Limited (BBIL) on Friday announced that its COVID-19 vaccine Covaxin has proven to be ...
PM Modi to inaugurate Biotech Startup Expo on Thursday-
By PTI NEW DELHI: Prime Minister Narendra Modi will inaugurate the Biotech Startup Expo – 2022 here on June 9, ...
WHO suspends UN supply of Covaxin; Bharat Biotech says no impact on efficacy-
Express News Service NEW DELHI: The World Health Organisation (WHO) has said it has suspended the supply through United Nations ...
DCGI allows Bharat Biotech to conduct phase-III trials for COVID’s intranasal booster dose-
By PTI NEW DELHI/ HYDERABAD: India’s drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for ...
Bharat Biotech seeks full marketing approval from DCGI for its COVID vaccine Covaxin-
By PTI NEW DELHI: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its ...
Covaxin booster effective in neutralising Omicron, says Bharat Biotech-
Express News Service NEW DELHI: Covaxin maker Bharat Biotech on Wednesday claimed that the booster shot of the Covid vaccine ...
Third dose of Covaxin beneficial for highest protection, says Bharat Biotech citing study-
Express News Service NEW DELHI: A third booster dose of Covaxin, the Covid19 vaccine by Bharat Biotech, is safe and ...
Covaxin triggers higher antibody response in kids than adults: Bharat Biotech cites trial data-
Express News Service NEW DELHI: Days after the government announced that 15 to 17-year-olds in India will be eligible for ...
Bharat Biotech seeks nod for phase-three trials of intranasal COVID vaccine as booster dose-
By PTI HYDERABAD: Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its ...
